Medicine and Diagnostic Access
Insulin was less available in public-sector primary care in FCVs than in non-FCVs. Public HbA1C testing availability was much lower in FCVs than in non-FCVs. Advanced monitoring and complication-screening technologies were less available i…
1 sources - 6 claims
Insulin was less available in public-sector primary care in FCVs than in non-FCVs. Public HbA1C testing availability was much lower in FCVs than in non-FCVs. Advanced monitoring and complication-screening technologies were less available in FCV public-sector facilities. Metformin availability was high in both FCV and non-FCV country groups. Recommended supply actions included reviewing essential medicines, strengthening forecasting and procurement, improving supply chains and storage, and expanding local manufacturing capacity. Medication cost and supply were persistent barriers across the region, with FCVs facing the greatest challenges in insulin and medicine availability.